期刊文献+

老年特发性膜性肾病诊治的研究进展

Research progress in the diagnosis and treatment of idiopathic membranous nephropathy in the elderly
下载PDF
导出
摘要 近年来,老年肾病综合征(NS)的发病率有逐年增高的趋势。在我国,特发性膜性肾病(IMN)是老年NS最重要的病因。虽然老年IMN的临床表现与年轻人相似,但由于老年IMN患者的自身特点及其对药物治疗不良反应明显较多、疾病进展相对迅速、预后较差,因此在对其进行诊治时,我们应重视疾病的早期诊断,及时采取针对性的治疗措施。目前主要的相关治疗方式包括保守治疗、免疫治疗。 In recent years,the incidence of nephrotic syndrome(NS)in the elderly has been increasing year by year.Idiopathic membranous nephropathy(IMN)is the most important cause of NS in the aged in our country.Although the clinical manifestations of elderly patients with IMN are similar to those of young people,due to the characteristics of elderly patients with IMN and their obvious adverse reactions to drug therapy,relatively rapid disease progression,and poor prognosis,we should pay attention to the early diagnosis of the disease and timely take targeted treatment measures when diagnosing and treating them.At present,the main treatment methods include conservative therapy and immunotherapy.
作者 洪小花 许勇芝 荆凯鹏 HONG Xiaohua;XU Yongzhi;JING Kaipeng(Department of Nephrology,Affiliated Hospital of Guangdong Medical University,ZhanjiangGuangdong524000)
出处 《当代医药论丛》 2023年第5期28-32,共5页
关键词 特发性膜性肾病 老年 免疫抑制 利妥昔单抗 idiopathic membranous nephropathy Old age Immunosuppression Rituximab
  • 相关文献

参考文献2

二级参考文献24

  • 1Ponticelli C, Passerini P. Membranous glomerulonephritis//Massry SG, Glassock RJ, et al. Massry & Glassock's Textbook of Nephrology. 4th ed. Philadelphia: Lippineott Williams Wilkins,2001,707 - 713.
  • 2Donadio JV Jr, Torres VE, Velosa JA, et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int, t988,33 (3) :708 - 715.
  • 3Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China:Analysis based on 13,519 renal biopsies. Kidney Int,2004, 66 (3) :920 - 923.
  • 4Ponticelli C, Zucchelli P, Imbasciati E, et al. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranousnephropathy. N Engl J Med, 1984,310 ( 15 ) :945 - 950.
  • 5Ponticelli C, Zucchelli P, Passerini P, et al. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephrophthy. N Engl J Med,1989,320(10) :8 - 13.
  • 6Ponticelli C, Zucchelli P, Passerini P, et al. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med, 1992,327 (9) :599 - 603.
  • 7Pontieelli C,Zuechelli P, Passerini P, et al. A I 0-year follow-up of a randomized study with methylpredisolone and chlorambucil in membranous nephropathy. Kidney Ittt, 1995,48 (5) :1600 - 1604.
  • 8Ponticelli C, Altieri P, Scolari F, et al. A randomized study comparing methylprednisolone plus chorambucil versus methylprednisolone plus cyclophosphamide in idiopathic methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol, 1998,9 ( 3 ) :444 - 450.
  • 9Eriguchi M, Oka H, Mizobuchi T, et al. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyelophosphamide and prednisolone. Nephrol Dial Transplant ,2009,24(10) :3082 - 3088.
  • 10Yuan J, Fang W, Zhang W, et al. Treatment of nephrotie idiopathicmembranous nephropathy with monthly i. v. pulse cyelophosphamidc and oral steroids: a single centre's retrospective study. Nephrology (Carlton) ,2011,16 (4) :440 - 445.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部